Dainippon Sumitomo Enters Drug Development Agreement With Healios
This article was originally published in PharmAsia News
Executive Summary
Dainippon Sumitomo has entered into a business alliance agreement with RIKEN-certified venture company Healios regarding drug development for eye diseases based on iPS technology.